REGN
Regeneron Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -3.6% ·
aandelenstroom -1.3% ·
netto nieuwe posities -7.4%
· formule
Brede distributie: dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 5 | -2 | 489.34K | $362.44M | n/a | −2 |
| Q2 2026 | 169 | -1 | 76.12M | $47.53B | +5 | −5 |
| Q1 2026 | 172 | -4 | 77.87M | $60.04B | +2 | −7 |
| Q4 2025 | 175 | 0 | 81.03M | $62.54B | +1 | n/a |
| Q3 2025 | 27 | -1 | 48.96M | $27.52B | n/a | −2 |
| Q2 2025 | 26 | +2 | 40.24M | $21.12B | +3 | −1 |
| Q1 2025 | 21 | +1 | 16.62M | $10.53B | +1 | n/a |
| Q4 2024 | 20 | -1 | 17.24M | $12.28B | n/a | −1 |
| Q3 2024 | 20 | +1 | 13.10M | $13.76B | +2 | −1 |
| Q2 2024 | 19 | n/a | 13.77M | $14.47B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 9.05M | -4.0% | $5.09B | 0.1% | ▼ Trim | 2 | SEC ↗ ×7 |
| 2 | BlackRock ✦ (passief) | 8.84M | -4.7% | $4.97B | 0.1% | ▼ Trim | 2 | SEC ↗ ×22 |
| 3 | JPMorgan Chase ✦ | 8.14M | n/a | $4.58B | 0.1% | n/c | 1 | SEC ↗ ×42 |
| 4 | State Street Global Advisors ✦ (passief) | 4.69M | -2.9% | $2.64B | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 5 | Dodge & Cox ✦ | 4.55M | +18.9% | $2.56B | 1.4% | ▲ Add | 6 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passief) | 2.54M | +2.9% | $1.42B | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Capital World Investors ✦ | 2.00M | +1.6% | $1.12B | 0.2% | ▲ Add | 6 | SEC ↗ |
| 8 | Fidelity (FMR) ✦ | 1.94M | -41.8% | $1.09B | 0.1% | ▼ Trim | 2 | SEC ↗ ×4 |
| 9 | Morgan Stanley ✦ | 1.45M | n/a | $815.84M | 0.0% | n/c | 1 | SEC ↗ ×17 |
| 10 | Goldman Sachs Group ✦ | 952.84K | n/a | $535.75M | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 11 | D. E. Shaw & Co. ✦ | 861.59K | +10.8% | $484.45M | 0.4% | ▲ Add | 6 | SEC ↗ ×2 |
| 12 | T. Rowe Price ✦ | 804.91K | +5.0% | $452.58M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 13 | AQR Capital Management ✦ | 721.35K | +528.7% | $405.60M | 0.3% | ▲ Add | 6 | SEC ↗ ×7 |
| 14 | Two Sigma Investments ✦ | 469.90K | -6.0% | $264.21M | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 15 | Marshall Wace ✦ | 386.88K | +61.3% | $217.53M | 0.2% | ▲ Add | 6 | SEC ↗ ×3 |
| 16 | Renaissance Technologies ✦ | 275.16K | +510.6% | $154.72M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 235.38K | +164.3% | $132.35M | 0.5% | ▲ Add | 6 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 230.23K | -66.2% | $129.45M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 19 | Point72 Asset Management ✦ | 201.50K | +40.8% | $113.30M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 20 | Millennium Management ✦ | 201.08K | -40.6% | $113.06M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 21 | Arrowstreet Capital ✦ | 192.58K | +3076.4% | $108.28M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 22 | Adage Capital Partners ✦ | 123.05K | +28.7% | $69.19M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 23 | Gotham Asset Management ✦ | 84.23K | +211.9% | $47.36M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 24 | ARK Investment Management ✦ | 12.14K | -3.7% | $6.83M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 25 | Wellington Management ✦ | 7.62K | -89.3% | $4.28M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 26 | Fisher Asset Management ✦ | 4.64K | +6.5% | $2.61M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 27 | GAMCO Investors ✦ | 646 | +7.3% | $363,226 | 0.0% | ▲ Add | 6 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Norges Bank | $628.15M | was 0.1% |
| Scion Asset Management | $7.88M | was 14.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,385 houders, 83.52M aandelen, $61.43B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 50 aand · $39,074
Officer · 127 aand · $97,701
Officer · 12 aand · $9,242
Officer · 283 aand · $218,351
Officer · 211 aand · $163,010
Officer · 224 aand · $173,242
Officer · 121 aand · $93,712
Officer · 376 aand · $291,573
Officer · 66 aand · $51,236
Officer · 38 aand · $29,555
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie